Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?

被引：0
|
作者：
I. Watermann
B. Schmitt
F. Stellmacher
J. Müller
R. Gaber
Ch. Kugler
N. Reinmuth
R. M. Huber
M. Thomas
P. Zabel
K. F. Rabe
D. Jonigk
A. Warth
E. Vollmer
M. Reck
T. Goldmann
机构：
[1] Clinical and Experimental Pathology,
[2] Research Center Borstel,undefined
[3] LungenClinic Grosshansdorf,undefined
[4] Airway Research Center North (ARCN),undefined
[5] Member of the German Center for Lung Research (DZL),undefined
[6] Ludwig Maximilians University (LMU),undefined
[7] Comprehensive Pneumology Center Munich,undefined
[8] (CPC-M),undefined
[9] Member of the German Center for Lung Research,undefined
[10] Thoracic Oncology Centre Munich,undefined
[11] Medical Clinic,undefined
[12] Research Center Borstel,undefined
[13] Institute of Pathology,undefined
[14] Hannover Medical School,undefined
[15] Biomedical Research in Endstage and Obstructive Lung Disease Hanover (BREATH),undefined
[16] Member of the German Center for Lung Research,undefined
[17] Institute of Pathology,undefined
[18] Heidelberg University,undefined
[19] Translational Lung Research Center (TLRC),undefined
[20] Member of the German Center for Lung Research,undefined
[21] Pathology,undefined
[22] Faculty of Medicine,undefined
[23] Alexandria University,undefined
来源：
Diagnostic Pathology | / 10卷
关键词：
Non-small cell lung Cancer (NSCLC); MET; Targeted therapies; Diagnostic; Phosphorylated MET; Immunohistochemistry; Fluorescence in situ hybridization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The Impact of C-Met Expression on the Immune Microenvironment and Survival in Locally Advanced Non-Small Cell Lung Cancer
    Xu, Xu.
    Xu, X.
    Zhu, Y.
    Ye, L.
    Zhang, Y.
    Zhang, W.
    Wu, L.
    Wu, C.
    Xu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S566 - S566
  • [22] MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met
    Luo, Wenting
    Huang, Bo
    Li, Zixuan
    Li, Haiying
    Sun, Limei
    Zhang, Qingfu
    Qiu, Xueshan
    Wang, Enhua
    PLOS ONE, 2013, 8 (05):
  • [23] Severe acute interstitial lung disease induced by crizotinib therapy in a patient with c-Met amplification non-small cell lung cancer
    Ji Youxin
    Zhang Zhongfa
    Nie Keke
    Lan Ketao
    Geng Chuanxin
    Liu Shichao
    Zhang Ling
    Zhang Zongchun
    Sun Lei
    Zou Xiao
    中华医学杂志（英文版）, 2014, (08) : 1600 - 1600
  • [24] Severe acute interstitial lung disease induced by crizotinib therapy in a patient with c-Met amplification non-small cell lung cancer
    Ji Youxin
    Zhang Zhongfa
    Nie Keke
    Lan Ketao
    Geng Chuanxin
    Liu Shichao
    Zhang Ling
    Zhang Zongchun
    Sun Lei
    Zou Xiao
    CHINESE MEDICAL JOURNAL, 2014, 127 (08) : 1600 - 1600
  • [25] Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification
    Caixia Ding
    Yanyi Qiu
    Juan Zhang
    Wei Wei
    Hongbian Gao
    Yong Yuan
    Xiaomin Wang
    BMC Pulmonary Medicine, 23
  • [26] Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification
    Ding, Caixia
    Qiu, Yanyi
    Zhang, Juan
    Wei, Wei
    Gao, Hongbian
    Yuan, Yong
    Wang, Xiaomin
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [27] Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer
    Xu, Chun-wei
    Wang, Wen-xian
    Wu, Mei-juan
    Zhu, You-cai
    Zhuang, Wu
    Lin, Gen
    Du, Kai-qi
    Huang, Yun-jian
    Chen, Yan-ping
    Chen, Gang
    Fang, Mei-yu
    THORACIC CANCER, 2017, 8 (05) : 417 - 422
  • [28] Analytical performance of a diagnostic immunohistochemical assay for MET protein (c-Met) in non-small cell lung cancer
    Inge, L.
    Admire, B.
    Foutch, T.
    Landowski, T.
    Lopez-Schultz, M.
    Gordon, K.
    Kapdia, M.
    Zhang, L.
    Mistry, A.
    Hotson, A.
    Bheddah, S.
    Li, M.
    McKee, L.
    VIRCHOWS ARCHIV, 2024, 485 : S141 - S141
  • [29] EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer
    Crees, Zachary D.
    Shearrow, Caleb
    Lin, Leo
    Girard, Jennifer
    Arasi, Kavin
    Bhoraskar, Aayush
    Berei, Joseph
    Eckburg, Adam
    Anderson, Austin D.
    Garcia, Christian
    Munger, Ariana
    Palani, Sunil
    Smith, Thomas J.
    Sreenivassappa, Shylendra B.
    Vitali, Connie
    David, Odile
    Puri, Neelu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [30] A MET Inhibitor in the Treatment of Metastatic Non-Small Cell Lung Cancer with MET Amplification
    Zhang, Tongtong
    Li, Junling
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S236 - S236
12345